What it does
MeAgain is a specialized health tracker for individuals using GLP-1 medications like Ozempic or Wegovy for weight management. The app provides a comprehensive toolkit to log medication doses, track nutrition (protein, fiber, water), monitor physical activity, and manage potential side effects. It builds a personalized daily plan based on a user's specific goals and medication regimen.
Where it shines
The app's most distinctive feature is its incredibly deep and personalized onboarding quiz (00:11-02:02). It goes far beyond basic health questions, asking about specific medications, dosages, and even which day of the week cravings are worst. This creates a strong sense of a bespoke experience. The app also excels at visualizing value early on, for example with a comparative weight loss graph (00:28) that pits its approach against "Restrictive Diets." Finally, its monetization is clever, deploying a mascot-driven, high-discount offer (02:37) to recapture users who initially reject the standard paywall.
UX highlights
- Interactive sliders: Instead of asking for numbers, the app uses engaging sliders for setting a dream weight (01:07) and choosing a weight loss pace with intuitive icons (01:14).
- Themed loading screen: The "Creating your plan" screen (02:02) cycles through relevant icons like water, exercise, and nutrition, making the wait feel purposeful.
- Visual value props: Simple graphs are used effectively to show the benefits of the app for both weight management (00:28) and medication effectiveness (01:29).
- Multi-select options: Users can select multiple concerns, such as side effects (01:35) or motivations (01:41), which adds to the feeling of a comprehensive, personalized profile.
Monetization & growth
MeAgain uses a hard paywall strategy, gating access to the main app until the user subscribes. The onboarding process is designed to build enough perceived value to justify the purchase. The primary paywall (02:15) presents two options (yearly and monthly) and uses price anchoring by showing the weekly cost ($0.77/week). Its most notable tactic is the exit-intent pop-up (02:37); if a user closes the paywall, they are immediately shown a steep, one-time discount offer, a smart move to convert price-sensitive users. The app also employs an aggressive mid-onboarding rating prompt (01:46) to solicit reviews.
Who it’s for
The target audience is clearly defined: individuals on a GLP-1 medication journey who want a dedicated digital companion. It’s for users who feel overwhelmed by generic calorie counters and desire a tool that understands the specific challenges and nuances of their treatment, from managing side effects to optimizing their diet and activity around their medication schedule.
Notes & opportunities
The onboarding is exceptionally long, which could be a significant point of user drop-off. While it builds investment, testing a shorter, more streamlined version could be worthwhile. After the user dismisses the special offer, they are returned to their plan summary (02:42) and then, upon proceeding, hit another paywall (02:45). This sequence feels slightly repetitive and could potentially be smoothed out to create a more seamless transition into the app for non-subscribers, if a freemium model were to be considered.